Thanks Upxdn - that was 30 mins is priceless to learn about the landscape/players. Sahm did a great job representing on a DNA therapeutic focused panel - something new learnt was that you can re-dose!
Having a robust large animal derived model is crucial competitive edge for a platform play - something which we’ll have in time.
Sahm nailed it outlining PYC optimal dosage methodology - data driven built on patient derived models and confirmed via large animal/NHP models.
I sense we are coming along nicely - with the FDA is very motivated/supportive to jointly agree on end points.
PYC Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)